However, women with DLB are more likely to exhibit concurrent amyloid and tau pathology (Diaz-Galvan et al., 2023; Ferreira et al., 2020) and show lower CSF α-synuclein and amyloid-β42 levels, shorter symptom duration, and more frequent hallucinations at diagnosis (van de Beek et al., 2022). The gene discussed is MAPT; the disease is Lewy body dementia.